The capability of our body cells to cease blood loss following a vascular injury by forming blood clot is vital to sustain health. Coagulation or clotting is the process of converting the liquid blood into a gel like clot to cease bleeding. A number of coagulation or clotting factors are involved in the route that leads to the physiological procedure called hemostasis. Hemostasis is the mechanism of clotting involving activation, adhesion, and aggregation of platelets mediated by a number of clotting factors eventually leading to repairing of the injured tissue. Any problem or absence of any of these factors can potentially lead to a rare but serious blood clotting disease and excessive bleeding. Some of the major coagulation factor disorders are the hemophilias and Von Willebrand disease.

The global blood coagulation factor market is anticipated to grow at a rapid pace owing to a multitude of factors. Blood coagulation factors falls under the infusible hemostats category. Developments in hemostasis technology has led to improvement of wide range of products that have enabled clinicians to provide proper emergency assistance to hemophilia patients. Factor VIII is a vital blood clotting protein in the human body. Its deficiency caused by a genetic defect results in a bleeding disorder called hemophilia A. Factor VIII concentrates are obtained from human plasma or via recombinant DNA technology to treat patients with hemophilia A. These factor therapies are infused intravenously through a vein in the arm or a port in the chest. Increase in the global trauma and accident cases is another driver of the blood coagulation factor market. Growth in the diagnosis rate of blood clotting diseases such as hemophilia and Von Willebrand disease is also expected to drive the global blood coagulation factor market during the forecast period. According to the data by published The Centers for Disease Control and Prevention (CDC), the incidence rate of hemophilia in the U. S. is 1 in every 5,000 male births. Von Willebrand disease (VWD), another bleeding disorder, is the most commonly occurring blood disorder that affects 1% of the population of the U.S. 1 in every 100 (almost 3.2 million) people in the U.S. is suffering from Von Willebrand disease (VWD). Huge number of patients with bleeding disorders increase the need for blood coagulation factor. Factor concentrates offer the most promising treatment results in these diseases. However, stringent regulatory policies and shortage in plasma supply can hamper the market growth during the forecast period.

In terms of geography, the global blood coagulation factor market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to remain the dominant markets for blood coagulation factor market due to the high yield of plasma products, advancements in technology, and increasing number of patients with blood disorders. Asia Pacific is expected to expand at a high CAGR owing to the strong economic growth, increase in the disposable income, rise in the health care infrastructure, and growing investments by market players in this region. India has the highest number of hemophilia patients in the worlds. According to the Indian Genetic Disorder Database, there were an estimated 55,000 hemophilia patients in India in 2015, of these 60% to 70% remain undetected. Moreover, the birth rate hemophilia in India is 32 per 1,000 births. Huge number of patients with bleeding disorders in the country is expected to offer large opportunities in the blood coagulation factor market in India.

Key players operating in the global blood coagulation factor market include Baxter International Inc, CSL Ltd., Inc., Grifols International SA, Kedrion S.P.A., Novo Nordisk A/S, and Octapharma AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Blood Coagulation Factor Market

Pre Book